X4 Pharmaceuticals (XFOR) Shares Outstanding (Entity) (2017 - 2025)
X4 Pharmaceuticals (XFOR) Shares Outstanding (Entity) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | 147.69 Mn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | - |
| 10 | X4 Pharmaceuticals | 163.25 Mn | -53.80 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 5.79 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 5.62 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Mar 31, 2024 | 5.60 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 5.49 Mn |
| Jun 30, 2023 | 5.48 Mn |
| Mar 31, 2023 | 4.07 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 937,495.00 |
| Sep 30, 2021 | 823,542.00 |
| Jun 30, 2021 | 819,413.00 |
| Mar 31, 2021 | 780,803.00 |
| Dec 31, 2020 | 543,470.00 |
| Sep 30, 2020 | 542,834.00 |
| Jun 30, 2020 | 539,151.00 |